Determination of reference intervals for serum complement C3 and C4 levels in Chinese Han ethnic males

Clinical Laboratory

Volumn 60, Issue 5, 2014, Pages 775-781

  Qin, Xue ^a   Lu, Yu ^a   Yang, Xiaoli ^a   Peng, Qiliu ^a   Wang, Jian ^a   Mo, Cuiju ^a   Wu, Junrong ^a   Sui, Jingzhe ^a   Liu, Yanqiong ^a   Huang, Xiuli ^a   Zhai, Limin ^a   Yang, Shi ^a   Li, Ruolin ^a   Li, Shan ^a   Yang, Xiaobo ^a   Gao, Yong ^a   Mo, Zengnan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Complement C3; Complement C4; Males; Reference intervals; Southern Han Chinese

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINESE; GROUPS BY AGE; HUMAN; MALE; NORMAL DISTRIBUTION; NORMAL HUMAN; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SMOKING HABIT;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHINA; COMPLEMENT C3; COMPLEMENT C4; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; REFERENCE VALUES; YOUNG ADULT;

EID: 84899888579     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130514     Document Type: Article

References (36)

1. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003;1609:127-43. (Pubitemid 36120719)
2. Goralski KB, Sinai CJ. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Can J Physiol Pharmacol 2007;85:113-32. (Pubitemid 46996110)
3. Zarkadis IK, Mastellos D, Lambris JD. Phylogenetic aspects of the complement system. Dev Comp Immunol 2001;25:745-62. (Pubitemid 32782636)
4. MacLaren R, Cui W, Cianflone K. Adipokines and the immune system: an adipocentric view. Adv Exp Med Biol 2008;632:1-21.
5. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999;42:23-30. (Pubitemid 29322284)
6. Lamprecht P, Moosig F, Gause A, et al. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2001;60:385-90. (Pubitemid 32242753)
7. Reid KB, Porter RR. The proteolytic activation systems of complement. Annu Rev Biochem 1981;50:433-64.
8. Yu CY, Chung EK, Yang Y, et al. Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex. Prog Nucleic Acid Res Mol Biol 2003;75:217-92. (Pubitemid 137639559)
9. Yang Y, Chung EK, Zhou B, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004;7:98-132.
10. Palikhe A, Sinisalo J, Seppanen M, et al. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events. Am J Cardiol 2007;99:890-5. (Pubitemid 46483274)
11. Gomo R, Sibanda EN. Determination of normal ranges for serum C3 and C4 levels in an adult Zimbabwean population. Cent Afr J Med 2002;48:137-41. (Pubitemid 44863879)
12. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature. J Clin Lab Anal 2004;18:9-13. (Pubitemid 38176996)
13. Kardar G, Oraei M, Shahsavani M, et al. Reference Intervals for Serum Immunoglobulins IgG, IgA, IgM and Complements C3 and C4 in Iranian Healthy Children. Iran J Public Health 2012;41:59-63.
14. Fuentes-Arderiu X, Alonso-Gregorio E, Alvarez-Funes V, et al. Multicentre physiological reference intervals for serum concentrations of immunoglobulins A, G and M, complement C3c and C4 measured with Tina-Quant reagents systems. Clin Chem Lab Med 2007;45:387-90.
15. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol 2010;133:180-6.
16. Ichihara K, Itoh Y, Min WK, et al. Diagnostic and epidemiological implications of regional differences in serum concentrations of proteins observed in six Asian cities. Clin Chem Lab Med 2004;42:800-9. (Pubitemid 39137230)
17. Siest G. Study of reference values and biological variation: a necessity and a model for Preventive Medicine Centers. Clin Chem Lab Med 2004;42:810-6. (Pubitemid 39137231)
18. Ichihara K, Itoh Y, Lam CW, et al. Sources of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals. Clin Chem 2008;54:356-65. (Pubitemid 351302636)
19. EMHF. Men's Health around the World: A review of policy and progress across countries. 2009.
20. Horowitz GL. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. Third edition. CLSI document C28-A3. Wayne: Clinical and Laboratory Standards Institute 2008.
21. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:1-8. (Pubitemid 38176995)
22. Onat A, Hergenc G, Can G, Kaya Z, Yuksel H. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Metabolism 2010;59:628-34.
23. Johnson AM, Hyltoft Petersen P, Whicher JT, Carlstrom A, MacLennan S. Reference intervals for serum proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK. Clin Chem Lab Med 2004;42:792-9. (Pubitemid 39137229)
24. Kielmann AA, Curcio LM. Complement (C3), nutrition, and infection. Bull World Health Organ 1979;57:113-21.
25. Khan N, Afaq F, Mukhtar H. Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett 2010;293:133-43.
26. Robbins RA, Nelson KJ, Gossman GL, Koyama S, Rennard SI. Complement activation by cigarette smoke. Am J Physiol 1991;260:L254-9.
27. van Greevenbroek MM, Jacobs M, van der Kallen CJ, et al. Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study). Int J Cardiol 2012;154:158-62.
28. Onat A, Hergenc G, Ayhan E, et al. Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks. Diabet Med 2009;26:981-8.
29. Sopena B, Martinez-Vazquez C, de la Fuente J, et al. Serum levels of immunoglobulins and complement in alcoholic liver disease. Rev Clin Esp 1993;193:419-23.
30. Oyeyinka GO, Aiyedun BA, Erasmus RT, Adewoye HO, Adetoro OO, Adedoyin MA. Complement and immunoglobulin levels in Ilorin Nigeria, and environ. Afr J Med Med Sci 1995;24:9-16.
31. Lahti A, Petersen PH, Boyd JC, Rustad P, Laake P, Solberg HE. Partitioning of nongaussian-distributed biochemical reference data into subgroups. Clin Chem 2004;50:891-900. (Pubitemid 38543668)
32. Lahti A. Partitioning biochemical reference data into subgroups: comparison of existing methods. Clin Chem Lab Med 2004;42:725-33. (Pubitemid 39137220)
33. Onat A, Can G, Rezvani R, Cianflone K. Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta 2011;412:1171-9.
34. Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 2005;54:570-5.
35. Bei-Fan Z. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 2002;11 Suppl 8:S685-93.
36. Gojobori T, Yang X, Sun J, et al. Genome-Wide Association Study for Serum Complement C3 and C4 Levels in Healthy Chinese Subjects. PLoS Genetics 2012,8:e1002916.